Radiosensitization by an anti-EGFR single chain antibody in human head and neck cancer cells

被引：0
|
作者：
Bonner, J. [1 ]
Trummell, H. Q. [1 ]
Sanford, L. L. [1 ]
Raisch, K. P. [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2007年 / 82卷
关键词：
D O I：
10.1016/S0167-8140(07)80098-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [31] Targeting of tumour cells with acquired resistance to anti-EGFR antibody
    Khelwatty, Said A.
    Essapen, Sharadah
    Seddon, Alan M.
    Fan, Zhen
    Modjtahedi, Helmout
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S73 - S73
  • [32] Effects of Anti-EGFR Antibody Cetuximab on Androgen-independent Prostate Cancer Cells
    Dhupkar, Pooja
    Dowling, Melissa
    Cengel, Keith
    Chen, Bin
    ANTICANCER RESEARCH, 2010, 30 (06) : 1905 - 1910
  • [33] Cloning and Expression of the Variable Regions of Anti-EGFR Monoclonal Antibody in E-coli for Production of a Single Chain Antibody
    Jalalypour, Farzaneh
    Farajnia, Safar
    Mahmoudi, Fatemeh
    Baradaran, Behzad
    Farajzadeh, Davoud
    Rahbarnia, Leila
    Majidi, Jafar
    IRANIAN JOURNAL OF BIOTECHNOLOGY, 2014, 12 (02)
  • [34] Concurrent chemoradiation (CCRT) or radiotherapy with anti-EGFR directed monoclonal antibody (anti-EGFR) or CCRT plus anti-EGFR in locoregionally advanced head-and-neck squamous cell carcinoma (LA-HNSCC): a comprehensive review of randomized data
    Specenier, P.
    Janssens, K.
    Vermorken, J. B.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S105 - S106
  • [35] Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)
    Bossi, P.
    Minuti, G.
    Brana, I.
    Garcia, V. Moreno
    Boni, V.
    Jamme, P.
    Call, J. A.
    Yan, C.
    Barasa, B.
    Doze, P.
    Joe, A. K.
    Laus, G.
    Daste, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1610 - S1611
  • [36] Use of the humanized anti-EGFR monoclonal antibody h-R3 and radiotherapy in the treatment of advanced head and neck cancer patients.
    Crombet, T
    Osorio, M
    Cruz, T
    Renginfo, E
    Díaz, JR
    Del Castillo, R
    Torres, O
    Pérez, R
    Lage, A
    CLINICAL CANCER RESEARCH, 2000, 6 : 4558S - 4558S
  • [37] Panitumumab.: Oncolytic -: Anti-EGFR human monoclonal antibody.
    McIntyre, JA
    Martín, L
    DRUGS OF THE FUTURE, 2004, 29 (08) : 793 - 797
  • [38] Radiosensitization of head and neck cancer cells by the phytochemical agent sulforaphane
    Kotowski, Ulana
    Heiduschka, Gregor
    Brunner, Markus
    Czembirek, Cornelia
    Eder-Czembirek, Christina
    Schmidt, Rainer
    Fahim, Tammer
    Thurnher, Dietmar
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (09) : 575 - 580
  • [39] RON receptor tyrosine kinase in head and neck cancer: a potential target for overcoming resistance to anti-EGFR therapy
    Lu, Zhixin
    Takiar, Vinita
    Waltz, Susan E.
    CANCER RESEARCH, 2023, 83 (07)
  • [40] Panitumumab: A new anti-EGFR antibody for the treatment of advanced colorectal cancer
    Chu, Edward
    CLINICAL COLORECTAL CANCER, 2006, 6 (01) : 13 - 13
12345